Authors
Loading...
Real-world comparative study reveals distinct toxicity profiles of carmustine-substituted regimens in lymphoma after ASCT, suggesting personalized approaches.
Pang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: